First ever case of intermittent blindness reported

Article

A young woman is suffering from a condition that leaves her blind, but only for half the time. For the last four years, Natalie Adler's eyes have regularly clamped shut for three days every week, and then reopened for the next three days.

An Australian Professor has reported, what he believes to be the first ever case of an intermittently blinding condition. His patient is a young woman who is suffering from a condition that leaves her blind, but only for half the time. For the last four years, Natalie Adler's eyes have regularly clamped shut for three days every week, and then reopened for the next three days.

Professor Justin O'Day, head of neuro-ophthalmology at the Royal Eye and Ear Hospital in Melbourne, Australia has been unable to establish a definitive diagnosis, but believes Ms Adler may be affected by a form of blepharospasm. She appears to be the only person in the world suffering from this condition.

Ms Adler first suffered from swollen eyes four years ago, due to what her doctors believed was a staph and sinus infection. The closing of her eyes was at first intermittent, although the regular cycle of opening and closing was established within weeks. On days when her eyes are closed, Ms Adler is left with a small open slit in her left eye; the rest of the time, her eyes function normally although her left eyelid occasionally droops.

Although conceding that the regularity of the condition and the age of the patient make blepharospasm an unlikely diagnosis, Professor O'Day was unable to offer an alternative diagnosis.

Newsletter

Join ophthalmologists across Europe—sign up for exclusive updates and innovations in surgical techniques and clinical care.

Recent Videos
A photo of Seville, Spain, with the Congress on Controversies in Ophthalmology logo superimposed on it. Image credit: ©francovolpato – stock.adobe.com; logo courtesy COPHy
Anat Loewenstein, MD, Professor and Director, Department of Ophthalmology, Tel Aviv Medical Center, discusses the Congress on Controversies in Ophthalmology (COPHy)
Anat Loewenstein, MD, speaks about the 22nd Annual Angiogenesis, Exudation, and Degeneration Meeting in February 2025 and shares her global forecast for AI-driven home OCT
Sarah M. Thomasy, DVM, PhD, DACVO, a veterinary ophthalmologist at UC Davis, talks about how her research at the Glaucoma 360 symposium
I. Paul Singh, MD, an anterior segment and glaucoma specialist, discusses the Glaucoma 360 conference, where he participated in a panel discussion on the use of artificial intelligence (AI) in glaucoma care.
Charles Wykoff, MD, PhD, discusses his Floretina ICOOR presentation topic, retinal non-perfusion in diabetic retinopathy, with David Hutton, editor of Ophthalmology Times
Elizabeth Cohen, MD, discusses the Zoster Eye Disease study at the 2024 AAO meeting
Victoria L Tseng, MD, PhD, professor of ophthalmology and glaucoma specialist, UCLA
© 2025 MJH Life Sciences

All rights reserved.